Inactive Instrument

Calendar Santhera Pharmaceuticals Holding AG Xetra

Equities

S3F

CH0027148649

Chart calendar Santhera Pharmaceuticals Holding AG

63a92fba992295aed63afe64a.OGiOx6KUH7h3qDT6xxNN_aUa2S3W4LuUmIstvUoQkmI.QirGkPrlbosd0UWJ8iMdlp1Lgx7niuPA67gc6g9nwxRsUdmslaxl_BHhUw~188e9a00ade5d64203a6bc9f919de8db

Upcoming events on Santhera Pharmaceuticals Holding AG

2024-06-18 04:00 am Annual General Meeting
2024-09-03 Q2 2024 Earnings Release (Projected)
2025-04-23 Q4 2024 Earnings Release (Projected)
2025-09-02 Q2 2025 Earnings Release (Projected)
2026-04-22 Q4 2025 Earnings Release (Projected)

Past events on Santhera Pharmaceuticals Holding AG

2024-04-25 08:30 am Q4 2023 Earnings Call
2024-04-25 01:00 am Q4 2023 Earnings Release
2023-10-02 World Muscle Society Congress
2023-09-12 10:00 am H.C. Wainwright Global Investment Conference
2023-09-07 08:30 am Q2 2023 Earnings Call
2023-09-07 01:00 am Q2 2023 Earnings Release
2023-07-02 Reverse Split: 1 of 10
2023-06-28 PPMD Conference
2023-06-27 04:00 am Annual General Meeting
2023-04-27 08:30 am Q4 2022 Earnings Call
2023-04-27 01:00 am Q4 2022 Earnings Release
2023-03-18 MDA Clinical & Scientific Conference
2022-11-29 04:30 am Extraordinary Shareholders Meeting
2022-11-07 08:30 am Interim 2022 Earnings Call
2022-10-31 02:00 am Interim 2022 Earnings Release
2022-10-14 01:40 pm World Muscle Society Congress - Poster : #FP.27
2022-10-14 01:30 pm World Muscle Society Congress - Poster : #P.133
2022-10-12 03:00 pm World Muscle Society Congress - Poster : #P.71
2022-10-12 01:40 pm World Muscle Society Congress - Poster : #FP.03
2022-06-30 04:30 am Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CHF
Released
Forecast
Spread
75,4
76,1
-0.95%
15,0
15,0
0.05%
-1,60
8,00
-119.94%
7,47
0,00
-
103
8,29
1147%

51,1

EBITDA
Million CHF
Released
Forecast
Spread
-5,67
-1,92
-195.13%
-45,9
-42,0
-9.38%
-39,6
-25,0
-58.26%
-42,1
-35,0
-20.34%
0,00
0,00
-

-27,0

EBIT
Million CHF
Released
Forecast
Spread
-10,4
-5,30
-97.19%
-53,1
-51,5
-3.06%
-56,9
-29,0
-96.17%
-52,0
-39,0
-33.27%
68,8
-48,0
243.32%

-30,0

Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
-18,4
0,41
-4597.31%
-67,5
-62,5
-7.93%
-54,7
-39,0
-40.3%
-69,7
-47,0
-48.27%
0,00
0,00
-

-35,0

Net income
Million CHF
Released
Forecast
Spread
-19,0
0,41
-4738.88%
-67,7
-71,0
4.71%
-55,5
-39,0
-42.37%
-70,1
-47,0
-49.25%
0,00
0,00
-

-35,0

EPS
CHF
Released
Forecast
Spread
-17,3
0,37
-4775.68%
-50,8
-42,3
-20.09%
-16,2
-7,20
-125%
-11,7
-6,30
-85.71%
0,00
0,00
-

-2,81

Announcement Date24/03/2029/04/2110/06/2227/04/2325/04/24-

Quarterly results

Fiscal PeriodDecember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million CHF
Released
Forecast
Spread

1,85


1,99


2,05


2,40


5,70


10,3


13,7


21,4

EBIT
Million CHF
Released
Forecast
Spread

-10,5


-11,5


-12,6


-13,5













Announcement Date--------
  1. Stock Market
  2. Equities
  3. SANN Stock
  4. S3F Stock
  5. Calendar Santhera Pharmaceuticals Holding AG